Pharmacists can not only help manage physical toxicities of cancer therapies, they can help develop treatment plans that lower other toxicities, such as time and cost. Having a solid understanding of oncology diseases and treatments allows pharmacists to fully participate in patient care. We support clinicians in developing that baseline knowledge through robust online training programs.
I help pharmacists learn oncology 🔆 CEO (Chief Evangelist of Oncology) 🔆 LinkedIn Top Voice
Have you heard of time toxicity as a complication of cancer treatment? Time toxicity is a complication of many healthcare conditions and treatments, including cancer. It represents the time a patient needs to devote to receiving care. If you or a loved one have dealt with the US healthcare system as a patient, you likely know exactly what this means. Time toxicity is not just the time at the doctor's office, it's all the adjacent activities around those visits. And for patients undergoing cancer treatment, those tasks can be monumental. This is why treatments with fixed durations are important. If we can get good disease outcomes with a therapy that has a finite treatment period, that provides huge benefits to our patients; they can reduce their time toxicity as well as drug and cost toxicities. An example of this is mosunetuzumab, a first-in class bispecific antibody that targets CD20. It has a fixed duration treatment option for patients with follicular lymphoma, which is ~6 months if a complete response is achieved and ~12 months for a partial response. Read the JCO article on time toxicity in the comments 👇 --- 📌 Whenever you’re ready to prioritize having a solid oncology clinical knowledgebase for you or your staff, the Enjoy Learning Oncology (ELO) program can help you I’m Kelley 👋 and I help pharmacists learn the complex world of oncology #LearnOncology #Pharmacists #OncologyPharmacists KelleyCPharmD
